The collaboration between
- With this option exercise, we believe Orion has selected considerably differentiated bispecific antibodies that could lead to highly innovative treatments, says Alligator's CEO Søren Bregenholt.
Read the article at biostock.se:
Orion option exercise triggers milestone payment for Alligator - BioStock
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
https://news.cision.com/alligator-bioscience/r/biostock--orion-option-exercise-triggers-milestone-payment-for-alligator,c3971903
(c) 2024 Cision. All rights reserved., source